Literature DB >> 10101361

[Control of percutaneous biopsy with CT fluoroscopy].

J J Froelich1, N Ishaque, B Saar, J Regn, E M Walthers, F Mauermann, K J Klose.   

Abstract

PURPOSE: Clinical evaluation of CT fluoroscopy and comparison with conventional CT guidance for monitoring of non-pulmonary percutaneous biopsy procedures.
MATERIALS AND METHODS: 20 non-pulmonary CT-guided biopsy procedures were prospectively performed either with CT fluoroscopy or with conventional CT guidance. CT fluoroscopy was performed using 120 kV and 50, 70 or 90 mA at a frame-rate of three or six images per second. Number of punctures and biopsies, procedure times, radiation doses and histologic results were analyzed separately for conventional CT guidance and for CT fluoroscopy.
RESULTS: With CT fluoroscopy, yield of biopsies was improved (p = 0.005, t-test) and procedure times were shorter than for conventional CT guidance (11.4 +/- 6.0 vs. 23.6 +/- 13.8 min; p = 0.03, t-test). Analysis of procedure related radiation exposure and histologic outcome showed no significant difference between conventional and fluoroscopic CT-guided procedures (p > 0.05, t-test).
CONCLUSIONS: CT fluoroscopy facilitates guidance of percutaneous biopsy procedures. Compared to conventional CT assistance, procedure times are decreased while yield of biopsies is improved.

Mesh:

Year:  1999        PMID: 10101361

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  3 in total

1.  CT-guided intervention using a patient laser marker system.

Authors:  R Kloeppel; T Weisse; F Deckert; W Wilke; S Pecher
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

2.  [CT fluoroscopy].

Authors:  P Rogalla; R Juran
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

3.  MR-guided biopsies of lesions in the retroperitoneal space: technique and results.

Authors:  S Zangos; K Eichler; A Wetter; T Lehnert; R Hammerstingl; T Diebold; P Reichel; C Herzog; M-L Hansmann; M G Mack; T J Vogl
Journal:  Eur Radiol       Date:  2005-07-30       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.